FindTrial
Sign In

Research on detection and clinical significance of circulating tumour cell (CTC) in peripheral circulation of patient with renal cell carcinoma

Research on detection and clinical significance of circulating tumour cell (CTC) in peripheral circulation of patient with renal cell carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014331
Enrollment
Unknown
Registered
2018-01-06
Start date
2014-01-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Cancer

Interventions

Gold Standard:CellSearch detects Circulating tumor cells, CTCs
Index test:CTC-Biopsy&#32
detects&#32
Circulating&#32
tumor&#32
cells,&#32
CTCs

Sponsors

Shandong Cancer Hospital Affiliated to Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged over 18; confirmed diagnosed with kidney cancer by pathological examination; generally good body condition, ECOG score=2, tolerable for blood collection, surgery, and medical treatment; have not received any anti-tumor treatment before admittd to hospital.

Exclusion criteria

Exclusion criteria: Patients diagnosed with benign renal tumor by pathological examination; refused to sign the informed consent

Design outcomes

Primary

MeasureTime frame
Presence of circulating tumor cells in peripheral blood;Progression-free survival (PFS);Overall survival (OS);—

Countries

China

Contacts

Public ContactZou Benkui

Shandong Cancer Hospital Affiliated to Shandong University

eric11216@163.com+86 13791036733

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026